It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

A new study shows that the US is still behind in controlling the price of prescription drugs. One doctor explains why America ...

Independent UK and Ireland SAP User Group chair describes upgrade as a marathon, not a sprint, but says SAP Rise is also ...

Plans to build 112 homes on land once occupied by Pfizer have been approved - but none of the properties will be classed as ...

Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s treatment for classic galactosemia.

Joe Biden’s decision to pardon his son Hunter marks a new low for the Democrats. As Adrian Vermeule has noted, dredging up ...

A healthy 9-year-old boy presented to our dermatology clinic for evaluation of a 2-year history of a bruise-like indurated plaque on his temple after a head-to-head collision with another child ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and ...